Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Teva Pharmaceutical Industries Ltd. (TEVA) had Income from Continuous Operations of $-419.00M for the most recently reported fiscal quarter, ending 2024-03-31.
| Income Statement Financials | |
$3.82B |
|
$-139.00M |
|
$2.05B |
|
$1.77B |
|
$4.04B |
|
$-217.00M |
|
$-250.00M |
|
$-467.00M |
|
$-467.00M |
|
$-415.00M |
|
|
Income from Continuous Operations |
$-419.00M |
$-419.00M |
|
$-415.00M |
|
$-217.00M |
|
$55.00M |
|
1.12B |
|
1.12B |
|
$-0.12 |
|
$-0.12 |
|
| Balance Sheet Financials | |
$12.30B |
|
$5.62B |
|
$30.48B |
|
$42.77B |
|
$13.79B |
|
$16.58B |
|
$21.44B |
|
$35.23B |
|
$7.54B |
|
$-14.52B |
|
$7.54B |
|
1.13B |
|
| Cash Flow Statement Financials | |
$-124.00M |
|
$144.00M |
|
$-151.00M |
|
$3.23B |
|
$2.99B |
|
$-236.00M |
|
$28.00M |
|
$-78.00M |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.89 |
|
-- |
|
-- |
|
0.69 |
|
2.60 |
|
46.37% |
|
-5.68% |
|
-5.68% |
|
-- |
|
-12.23% |
|
-3.64% |
|
$-248.00M |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
0.52 |
|
1.10 |
|
81.45 |
|
-5.55% |
|
2.89% |
|
-0.98% |
|
-1.74% |
|
$6.66 |
|
$-0.22 |
|
$-0.11 |
|